[Preclinical and clinical evaluation of micronomicin sulfate eye drops (author's transl)].
D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents; D001424:Bacterial Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004353:Drug Evaluation, Preclinical; D005128:Eye Diseases / Q000188:drug therapy*; D005839:Gentamicins / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006168:Guinea Pigs; D006801:Humans; D009883:Ophthalmic Solutions; D010865:Pilot Projects; D011292:Premedication; D011817:Rabbits
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D009883:Ophthalmic Solutions; C037545:micronomicin